MedPath

Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women

Not Applicable
Recruiting
Conditions
Bone Disease, Metabolic
Interventions
Dietary Supplement: Prune
Registration Number
NCT06184646
Lead Sponsor
San Diego State University
Brief Summary

The objective of this study is to examine if calcium and vitamin D supplements and/or prune can prevent bone loss in postmenopausal women.

Detailed Description

Two hundred randomly assigned to one of two treatment groups: 1) 30 g prunes and 2) control (0 g prunes). Both groups received 500 mg calcium and 400 IU Vitamin D as a daily supplement. Blood samples are collected at baseline, 12 and 24 months to assess biomarkers of bone turnover. Physical activity recall and food records are obtained at baseline, 12 and 24 months to examine physical activity and dietary confounders as potential covariates. Dual-energy x-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT) will be completed at baseline, 12 and 24 months to examine bone mineral density and structure.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Postmenopausal
  • BMD t-score is between 0.5 and 2 SD below the mean
  • Not on hormone replacement therapy (HRT) and/or other pharmacological agents known to affect bone for at least three months prior to initiation of the study
Exclusion Criteria
  • Women whose BMD t-score at any site falls below 2.5 SD of the mean
  • Subjects receiving endocrine (e.g., prednisone, other glucocorticoids) or neuroactive (e.g., dilantin, phenobarbital) drugs or any drugs known to influence bone and calcium metabolism
  • Subjects who smoke cigarettes or vape
  • Regular consumption of dried plum or prune juice

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
30 g prune/dayPruneParticipants receive 500 mg calcium and 400 IU vitamin D daily for 24 months and 30 g of prune daily for 24 months.
Primary Outcome Measures
NameTimeMethod
Changes from baseline in bone mineral density at 12 and 24 monthsBaseline, 12 months, and 24 months

bone mineral density as assessed by dual energy x-ray absorptiometry

Secondary Outcome Measures
NameTimeMethod
Changes from baseline in bone specific alkaline phosphatase at 12 months and 24 monthsBaseline, 12 months, and 24 months

bone specific alkaline phosphatase (BAP) as assessed with ELISA

Changes from baseline in tartrate acid phosphatase-5b at 12 months and 24 monthsBaseline, 12 months, and 24 months

tartrate acid phosphatase-5b (TRAP5b) as assessed with ELISA

Trial Locations

Locations (1)

San Diego State University

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath